These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 19258584)

  • 1. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.
    Ho PM; Maddox TM; Wang L; Fihn SD; Jesse RL; Peterson ED; Rumsfeld JS
    JAMA; 2009 Mar; 301(9):937-44. PubMed ID: 19258584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.
    Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A
    J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.
    Wu CY; Chan FK; Wu MS; Kuo KN; Wang CB; Tsao CR; Lin JT
    Gastroenterology; 2010 Oct; 139(4):1165-71. PubMed ID: 20600012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
    Hsiao FY; Mullins CD; Wen YW; Huang WF; Chen PF; Tsai YW
    Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1043-9. PubMed ID: 21823195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.
    Lin CF; Shen LJ; Wu FL; Bai CH; Gau CS
    Br J Clin Pharmacol; 2012 Nov; 74(5):824-34. PubMed ID: 22364155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study.
    Jackson LR; Peterson ED; McCoy LA; Ju C; Zettler M; Baker BA; Messenger JC; Faries DE; Effron MB; Cohen DJ; Wang TY
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.
    Nicolau JC; Bhatt DL; Roe MT; Lokhnygina Y; Neely B; Corbalán R; Leiva-Pons JL; Martinez F; Goodman SG; Winters KJ; Verheugt FW; Armstrong PW; White HD; Fox KA; Prabhakaran D; Ohman EM;
    Am Heart J; 2015 Oct; 170(4):683-694.e3. PubMed ID: 26386792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.
    Ho PM; Peterson ED; Wang L; Magid DJ; Fihn SD; Larsen GC; Jesse RA; Rumsfeld JS
    JAMA; 2008 Feb; 299(5):532-9. PubMed ID: 18252883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
    Bhurke SM; Martin BC; Li C; Franks AM; Bursac Z; Said Q
    Pharmacotherapy; 2012 Sep; 32(9):809-18. PubMed ID: 22744772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
    Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
    Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.
    Weisz G; Smilowitz NR; Kirtane AJ; Rinaldi MJ; Parvataneni R; Xu K; Stuckey TD; Maehara A; Witzenbichler B; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Mazzaferri EL; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26458411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populations.
    Ernst FR; Johnston S; Curkendall S; Mozaffari E; Stemkowski S
    Am J Health Syst Pharm; 2011 Jun; 68(11):1015-24. PubMed ID: 21593230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.
    Banerjee S; Weideman RA; Weideman MW; Little BB; Kelly KC; Gunter JT; Tortorice KL; Shank M; Cryer B; Reilly RF; Rao SV; Kastrati A; de Lemos JA; Brilakis ES; Bhatt DL
    Am J Cardiol; 2011 Mar; 107(6):871-8. PubMed ID: 21247527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
    Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
    J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.
    Mahabaleshwarkar RK; Yang Y; Datar MV; Bentley JP; Strum MW; Banahan BF; Null KD
    Curr Med Res Opin; 2013 Apr; 29(4):315-23. PubMed ID: 23362935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
    Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
    Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.
    Gaglia MA; Torguson R; Hanna N; Gonzalez MA; Collins SD; Syed AI; Ben-Dor I; Maluenda G; Delhaye C; Wakabayashi K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2010 Mar; 105(6):833-8. PubMed ID: 20211327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.